These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 1905196)
1. Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat. Barrett JS; Wagner JG; Fisher SJ; Wahl RL Cancer Res; 1991 Jul; 51(13):3434-44. PubMed ID: 1905196 [TBL] [Abstract][Full Text] [Related]
2. Postural effects on peritoneal transport and systemic uptake of radiolabeled monoclonal antibodies. Barrett JS; Fisher SJ; Wahl RL Cancer Immunol Immunother; 1997 May; 44(3):173-8. PubMed ID: 9191877 [TBL] [Abstract][Full Text] [Related]
3. A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients. Griffin TW; Bokhari F; Collins J; Stochl M; Bernier M; Gionet M; Siebecker D; Wertheimer M; Giroves ES; Greenfield L Cancer Immunol Immunother; 1989; 29(1):43-50. PubMed ID: 2706639 [TBL] [Abstract][Full Text] [Related]
4. Photoacoustic imaging of the dynamics of a dye-labeled IgG4 monoclonal antibody in subcutaneous tissue reveals a transient decrease in murine blood oxygenation under anesthesia. Khadria A; Paavola CD; Maslov K; Brown-Augsburger PL; Grealish PF; Lozano E; Blankenship RL; Cao R; Shi J; Beals JM; Oladipupo SS; Wang LV J Biomed Opt; 2023 Nov; 28(11):116002. PubMed ID: 38078154 [TBL] [Abstract][Full Text] [Related]
5. Modeling drug transport and absorption in subcutaneous injection of monoclonal antibodies: Impact of tissue deformation, devices, and physiology. de Lucio M; Leng Y; Wang H; Vlachos PP; Gomez H Int J Pharm; 2024 Aug; 661():124446. PubMed ID: 38996825 [TBL] [Abstract][Full Text] [Related]
6. The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage. Wahl RL; Barrett J; Geatti O; Liebert M; Wilson BS; Fisher S; Wagner JG Cancer Immunol Immunother; 1988; 26(3):187-201. PubMed ID: 3383203 [TBL] [Abstract][Full Text] [Related]
7. Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. Mattes MJ J Natl Cancer Inst; 1987 Oct; 79(4):855-63. PubMed ID: 2443739 [TBL] [Abstract][Full Text] [Related]
8. Investigations into the route of uptake and pharmacokinetics of intraperitoneally-administered monoclonal antibodies: I. Transdiaphragmatic blockade of the terminal lymphatics in the rat. Barrett JS; Wahl RL; Wagner JG; Brown R; Fisher SJ Cancer Immunol Immunother; 1990; 31(6):365-72. PubMed ID: 2386982 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418 [TBL] [Abstract][Full Text] [Related]
10. PBPK model for antibody disposition in mouse brain: validation using large-pore microdialysis data. Wu S; Le Prieult F; Phipps CJ; Mezler M; Shah DK J Pharmacokinet Pharmacodyn; 2022 Dec; 49(6):579-592. PubMed ID: 36088452 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies? Al Shoyaib A; Archie SR; Karamyan VT Pharm Res; 2019 Dec; 37(1):12. PubMed ID: 31873819 [TBL] [Abstract][Full Text] [Related]
12. Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge. Robinson SR; Rahe MC; Gray DK; Martins KV; Murtaugh MP Virus Res; 2018 Mar; 248():13-23. PubMed ID: 29408442 [TBL] [Abstract][Full Text] [Related]